Page last updated: 2024-10-31

midodrine and Paraganglioma

midodrine has been researched along with Paraganglioma in 1 studies

Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.

Paraganglioma: A neural crest tumor usually derived from the chromoreceptor tissue of a paraganglion, such as the carotid body, or medulla of the adrenal gland (usually called a chromaffinoma or pheochromocytoma). It is more common in women than in men. (Stedman, 25th ed; from Segen, Dictionary of Modern Medicine, 1992)

Research Excerpts

ExcerptRelevanceReference
"Plasma metanephrines have become the biochemical test of choice for suspected phaeochromocytomas and paragangliomas in many institutions."3.88Falsely elevated plasma metanephrine in patients taking midodrine. ( Boot, C; Emms, H; Farah, G; Grossman, AB; Kyle, C; Lam, L; Madhavaram, H; McFadden, M; Ou, ZQ; Shine, B; Toole, B; Woollard, G, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Emms, H1
Farah, G1
Shine, B1
Boot, C1
Toole, B1
McFadden, M1
Lam, L1
Ou, ZQ1
Woollard, G1
Madhavaram, H1
Kyle, C1
Grossman, AB1

Other Studies

1 other study available for midodrine and Paraganglioma

ArticleYear
Falsely elevated plasma metanephrine in patients taking midodrine.
    Annals of clinical biochemistry, 2018, Volume: 55, Issue:4

    Topics: Adrenal Gland Neoplasms; Adrenergic alpha-1 Receptor Agonists; Adult; Chromatography, High Pressure

2018